Major features of immunesenescence, including reduced thymic output, are ameliorated by high levels of physical activity in adulthood.
Niharika Arora Duggal, Ross D Pollock, Norman R Lazarus...
https://pubmed.ncbi.nlm.nih.gov/29517845/Actively Recruiting
Led by Buck Institute for Research on Aging · Updated on 2024-10-08
80
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are investigating the differences in muscle, blood, and urine samples between older adults aged 65 to 80 who are either sedentary or elite athletes for their age. This observational study aims to understand how physical activity affects aging by comparing these two groups through various biological and functional tests. The study involves healthy older adults who meet specific activity and health criteria to explore aging biomarkers. Participants will take part in three visits within 12 weeks. The first visit includes screening, consent, medical history, physical assessments like ECG and body composition, and exercise testing using a bicycle test and physical function exercises. The second visit involves maximal exercise tests, quality of life surveys, and cognitive assessments, after which participants are assigned to either the sedentary or elite athlete group. The third visit collects muscle tissue via biopsy along with blood samples. Optional follow-up visits may occur at 12 and 24 months after completing the main study. During the study, participants undergo detailed physical and cognitive testing, including strength, endurance, and walking tests. Researchers collect muscle, blood, and urine samples to analyze cellular aging, protein and metabolite concentrations, mitochondrial function, immune cell activity, and gene expression. Monitoring includes cognitive function and quality of life assessments. The studys primary focus is on muscle cellular aging using advanced transcriptomic techniques, with involvement lasting up to two years if follow-up visits are completed.
CONDITIONS
Molecular Optimization Via Exercise (MOVE)
B
Briannaa Stubbs, DPhil
J
John C Newman, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Buck Institute for Research on Aging
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - Up to 12 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Within 12 weeks from enrollment
Participants complete exercise testing, quality of life, and cognitive assessments to determine cohort assignment.
1 in-person visit
Duration - Within 12 weeks from enrollment
Participants provide thigh muscle needle biopsy and blood samples for biomarker analysis.
1 in-person visit
Duration - Up to 24 months after main study completion
Optional follow-up visits to assess long-term changes in biomarkers.
Optional visits at 12 and 24 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Niharika Arora Duggal, Ross D Pollock, Norman R Lazarus...
https://pubmed.ncbi.nlm.nih.gov/29517845/Stephen D R Harridge, Norman R Lazarus
https://pubmed.ncbi.nlm.nih.gov/28228482/Buck Institute for Research on Aging
Lead Sponsor